Prashant Mehra

New Zealand dairy giant Fonterra has confirmed plans to divest its global consumer business along with businesses in Oceania and Sri Lanka, and has lifted its forecast for full-year farmgate milk price.

Mineral Resources says it was aware of allegations of tax evasion against managing director Chris Ellison since 2022 but did not consider these materially price sensitive since it related to historic matters.

EBOS Group says it is targeting new revenues in light of the changed dynamics of the Australian community pharmacy industry and outlined plans for cost savings.

Westgold Resources has reported a lift in production for the September quarter at its projects in Western Australia and reaffirmed its full-year guidance.

Biotech company Clarity Pharmaceuticals will start a second Phase III clinical trial of its prostate cancer diagnostic 64Cu-SAR-bisPSMA product after positive feedback from the US Food and Drug Administration, lifting its shares.

Biotech company Clarity Pharmaceuticals has entered into a clinical manufacturing agreement to produce its diagnostic 64Cu-SAR-bisPSMA product for prostate cancer for its phase III clinical trials.

Medical imaging provider Pro Medicus has secured an eight-year contract renewal in the US from St Louis-based Mercy Health.

Investment manager MFF Capital Investments has agreed to buy global fund manager Montaka Global as it looks to strengthen its capabilities.

The Australian sharemarket is set to open higher despite losses on Wall Street where investors awaited economic indicators and signals on upcoming interest rate cuts.

Apparel retailer KMD Brands has swung to a full-year loss as sales fell sharply amid weak consumer sentiment and softer trading.